Octave Specialty (OSG) Common Equity (2010 - 2026)

Octave Specialty's Common Equity history runs 17 years deep, the most recent figure standing at $833.6 million for Q1 2026.

• On a quarterly basis, Common Equity fell 13.71% year-over-year to $833.6 million in Q1 2026; TTM through Mar 2026 was $833.6 million, a 13.71% decrease from a year earlier, with the FY2025 full-year figure at $715.8 million, down 28.14% from the prior year.
• Common Equity advanced to $833.6 million in Q1 2026 per OSG's latest filing, from $715.8 million in the prior quarter.
• Across five years, Common Equity topped out at $1.7 billion in Q3 2024 and bottomed at $715.8 million in Q4 2025.
• The 5-year median for Common Equity is $1.1 billion (2022), against an average of $1.1 billion.
• Across the five-year window, Common Equity jumped 54.02% in 2023 and tumbled 49.5% in 2025, its largest moves.
• Year by year, Common Equity stood at $1.3 billion in 2022, then increased by 8.38% to $1.4 billion in 2023, then decreased by 29.58% to $996.1 million in 2024, then fell by 28.14% to $715.8 million in 2025, then advanced by 16.46% to $833.6 million in 2026.
• Per Business Quant, the three latest OSG Common Equity figures stand at $833.6 million (Q1 2026), $715.8 million (Q4 2025), and $843.4 million (Q3 2025).